Use of oligosaccharides for the treatment of connective tissues
CA 2288773 A1 · Owner: Robert, Alexandre Michel · Inventors: Castelli, Dominique; Robert, Alexandre Michel; Robert, Ladislas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns a use of at least one oligosaccharide possessing from 2 to 6 glycoside residues and having a galactose residue in a non-reducing terminal position, or of a derivative of such an oligosaccharide capable of being obtained by attachment of a hydrophobic radical for the , preparation of a composition intended for increasing the synthesis and/or decreasing the degradation of the proteoglycans of connective tissue.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 30, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 30, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 30, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.